Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.15% | -15.64% | -72.32% | -57.06% | -34.72% |
| Total Depreciation and Amortization | 22.62% | 9.30% | -14.68% | -26.86% | -34.23% |
| Total Amortization of Deferred Charges | 8.63% | 33.86% | 44.19% | 17.33% | 137.24% |
| Total Other Non-Cash Items | 45.69% | 13.64% | 665.43% | 638.87% | 560.52% |
| Change in Net Operating Assets | 102.36% | 128.65% | -123.62% | -1,883.42% | -558.42% |
| Cash from Operations | -1.55% | -5.28% | -27.06% | -30.73% | -25.21% |
| Capital Expenditure | -43.07% | -50.14% | -62.81% | -32.75% | -38.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61,012.79% | -59,413.43% | -1,639.42% | -36.40% | 57.98% |
| Cash from Investing | -783.04% | -772.13% | -89.28% | -33.67% | -38.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -30.18% | -31.30% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 22.14% | -132.06% | -145.99% | -148.03% | -155.60% |
| Cash from Financing | -19.17% | -55.46% | 183.25% | 52.12% | 26.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.02% | -160.12% | 504.02% | 86.09% | 25.80% |